Literature DB >> 8433217

Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry.

P Tosi1, M I Filipe, P Luzi, C Miracco, R Santopietro, R Lio, V Sforza, P Barbini.   

Abstract

The aim of this study was to try to place gastric intestinal metaplasia, type III (type III IM) in the stepwise chain of events from atrophic gastritis to cancer. A number of dysplastic, periulcer regenerative, and type III IM lesions were qualitatively diagnosed (and graded) blindly and independently by several pathologists. These lesions were further analysed by means of quantitative parameters, with the aim of differentiating dysplastic from regenerative changes. Inconsistencies between the qualitative and quantitative classification (about 7 per cent of cases) were eliminated and homogeneous groups (low-grade dysplasia, high-grade dysplasia, regenerative changes) were obtained. These cases were taken as the gold standard against which type III IM was compared. The results indicate that the great majority (91.4 per cent) of cases of type III IM fulfil the nuclear and architectural criteria for low-grade dysplasia.

Entities:  

Mesh:

Year:  1993        PMID: 8433217     DOI: 10.1002/path.1711690112

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

1.  Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma.

Authors:  Tsutomu Namikawa; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.

Authors:  Carlos A González; José M Sanz-Anquela; Javier P Gisbert; Pelayo Correa
Journal:  Int J Cancer       Date:  2013-02-05       Impact factor: 7.396

3.  LI-cadherin: a marker of gastric metaplasia and neoplasia.

Authors:  C Grötzinger; J Kneifel; D Patschan; N Schnoy; I Anagnostopoulos; S Faiss; R Tauber; B Wiedenmann; R Gessner
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies.

Authors:  Hirokazu Yamaguchi; James R Goldenring; Michio Kaminishi; Jeffrey R Lee
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

5.  The gastric precancerous cascade.

Authors:  Pelayo Correa; M Blanca Piazuelo
Journal:  J Dig Dis       Date:  2012-01       Impact factor: 2.325

6.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

7.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

Review 8.  Assessing risks for gastric cancer: new tools for pathologists.

Authors:  Robert M Genta; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

9.  Immunohistochemical evaluation of keratin 20 expression in intestinal metaplasia types I to III.

Authors:  M J Schwerer; K Baczako
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

Review 10.  Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.

Authors:  Jiro Watari; Nancy Chen; Peter S Amenta; Hirokazu Fukui; Tadayuki Oshima; Toshihiko Tomita; Hiroto Miwa; Kheng-Jim Lim; Kiron M Das
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.